Boston Biomedical Pharma, based in Cambridge, MA, is dedicated to improving global health by driving innovative treatments in critical areas such as psychiatry, neurology, oncology, urology, women's health, rare diseases, and cell gene therapy.
With a focus on technology-driven approaches, Boston Biomedical Pharma's diverse pipeline of preclinical and clinical programs aims to deliver patient-first solutions faster and more efficiently to address unmet medical needs and improve patient outcomes.
Generated from the website